Category Archives: Non-U.S. Practice

Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07

Under what circumstances is injection a prohibited surgical method? Views of the EPO Enlarged Appeal Board in Treatment by surgery/MEDI-PHYSICS G 0001/07 .  Opinion From Paul Cole The present proceedings resulted from a referral in decision T 0992/03 relating to EP-A-1066537. … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , | Leave a comment

Novelty and Obviousness In An Empirical Research Field – The Decision of the UK Court of Appeal in Dr Reddy’s Laboratories v Eli Lilly

From Paul Cole The Lilly patent for olanzapine has been litigated in many jurisdictions including the US, Canada, the Czech Republic, Finland, Levitra order online Romania, Slovakia, Slovenia, Spain, China and Hungary. In US Court of Appeals for the Federal … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , | Leave a comment

Court Decision in China Recognizes Novelty in Dosage Limitations in Swiss-Form Claims

Peksung Intellectual Property Ltd sent an interesting article (link below) reporting that the Higher People’s Court of Beijing held that both dosage form and dosage amount should be treated as limitations in Swiss-form claims. These “administration-related features” are often ignored … Continue reading

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment

POST FROM AUSTRALIA – NON-ENGLISH LANGUAGE PUBLICATIONS MAY NOT BE CITABLE ART.

By Bill Bennett, Pizzeys, Canberra, AU A unique aspect of Australian Patent Law is the requirement that a reference must be “reasonably ascertained, understood and regarded as relevant” by the hypothetical skilled person before it can be applied in an … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , | Leave a comment